Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sandoz Zarxio Launch Still Faces Hurdles; ‘Chess Game’ With Amgen Continues

Executive Summary

Federal Circuit ruling frees Sandoz to begin marketing first U.S. biosimilar after Sept. 2 but it still must overcome pending infringement suit and chance Amgen will assert more patents.



Related Companies